Study Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer

Overview[ - collapse ][ - ]

Purpose Open-label, randomized, active-controlled, two-arm Phase III study to compare the efficacy and safety of AEZS-108 and doxorubicin. The study will include about 500 patients with endometrial cancer resistant to platinum/taxane-based chemotherapy.
ConditionEndometrial Cancer
InterventionDrug: AEZS-108 / zoptarelin doxorubicin
Drug: doxorubicin
PhasePhase 3
SponsorAEterna Zentaris
Responsible PartyAEterna Zentaris
ClinicalTrials.gov IdentifierNCT01767155
First ReceivedJanuary 9, 2013
Last UpdatedApril 24, 2014
Last verifiedSeptember 2013

Tracking Information[ + expand ][ + ]

First Received DateJanuary 9, 2013
Last Updated DateApril 24, 2014
Start DateApril 2013
Estimated Primary Completion DateJanuary 2016
Current Primary Outcome MeasuresCompare the overall survival (OS) of patients treated with AEZS-108 to the OS of patients treated with doxorubicin. [Time Frame: 3 years] [Designated as safety issue: No]
Current Secondary Outcome Measures
  • Compare efficacy based on objective response rate (ORR). [Time Frame: 3 years] [Designated as safety issue: No]
  • Compare efficacy based on progression-free survival (PFS). [Time Frame: 3 years] [Designated as safety issue: No]
  • Compare efficacy based on clinical benefit rate (CBR). [Time Frame: 3 years] [Designated as safety issue: No]

Descriptive Information[ + expand ][ + ]

Brief TitleStudy Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer
Official TitleRandomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Brief Summary
Open-label, randomized, active-controlled, two-arm Phase III study to compare the efficacy
and safety of AEZS-108 and doxorubicin. The study will include about 500 patients with
endometrial cancer resistant to platinum/taxane-based chemotherapy.
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
ConditionEndometrial Cancer
InterventionDrug: AEZS-108 / zoptarelin doxorubicin
267 mg/m2 by 2-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles for a maximun of 9 cycles
Drug: doxorubicin
60 mg/m2 by intravenous bolus injection or 1-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles
Study Arm (s)
  • Experimental: AEZS-108 / zoptarelin doxorubicin
    267 mg/m2 by 2-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles up to 9 cycles
  • Active Comparator: doxorubicin/ standard chemotherapy
    60 mg/m2 by intravenous bolus injection or 1-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles

Recruitment Information[ + expand ][ + ]

Recruitment StatusRecruiting
Estimated Enrollment500
Estimated Completion DateJanuary 2016
Estimated Primary Completion DateDecember 2015
Eligibility Criteria
Inclusion Criteria:

1. Women ≥ 18 years of age

2. Histologically confirmed endometrial cancer

3. Advanced (FIGO stage III or IV), recurrent or metastatic disease.

4. Measurable or non-measurable disease that has progressed since last treatment.

5. Patients who have progressed after prior first line treatment with platinum/taxane
based chemotherapy for advanced, recurrent or metastatic endometrial cancer.

6. Availability of fresh or archival FFPE tumor specimens for analysis of LHRH receptor
expression.

Exclusion Criteria:

1. ECOG performance status > 2.

2. Inadequate hematologic, hepatic or renal function

3. Red blood cell transfusion within 2 weeks prior to anticipated start of study
treatment.

4. History of myocardial infarction, unstable angina, or uncontrolled arrhythmia within
the past 6 months.

5. Impaired cardiac function defined as left ventricular ejection fraction (LVEF) < 50 %
as measured by MUGA or ECHO.

6. Planned concomitant use of potentially cardiotoxic medication

7. Chemo-, immune-, hormone-, or radiotherapy (including pre- or post-operative
brachytherapy) within 4 weeks prior to randomization.

8. Previous anthracycline-based chemotherapy.

9. Anticipated ongoing concomitant anticancer therapy during the study.

10. History of serious co-morbidity or uncontrolled illness that would preclude study
therapy, such as active tuberculosis or any other active infection.

11. Brain metastasis, leptomeningeal disease.

12. Pregnant or lactating female or female of child-bearing potential not employing
adequate contraception.

13. Receipt of 2 or more prior chemotherapy regimens for advanced, recurrent, or
metastatic endometrial cancer.

14. Prior treatment with AEZS-108.

15. Use of LHRH agonist or antagonist treatment within 6 months prior to randomization.

16. Malignancy within last 5 years except non-melanoma skin cancer.

17. Any concomitant disease or condition which would interfere with the subjects' proper
completion of the protocol assignment.

18. Concomitant or recent treatment with other investigational drug (within 8 weeks or 5
elimination half life times prior to anticipated start of study treatment).

19. Lack of ability or willingness to give informed consent.

20. Anticipated non-availability for study visits/procedures.
GenderFemale
Ages18 Years
Accepts Healthy VolunteersNo
ContactsContact: Ines Altemose
908-626-5510
IAltemose@aezsinc.com
Location CountriesUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Czech Republic, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom

Administrative Information[ + expand ][ + ]

NCT Number NCT01767155
Other Study ID NumbersAEZS -108-050
Has Data Monitoring CommitteeYes
Information Provided ByAEterna Zentaris
Study SponsorAEterna Zentaris
CollaboratorsNot Provided
Investigators Principal Investigator: David Scott Miller, MD University of Texas Southwestern Medical Center, Dallas, USAPrincipal Investigator: Hani Gabra, MD Imperial College London Hammersmith Campus, London, UK
Verification DateSeptember 2013

Locations[ + expand ][ + ]

St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States, 85013
Contact: Kelli Williamson | 602-406-6689
Principal Investigator: Lyndsay Willmott, Dr
Recruiting
University of California, Irvine - Medical Center
Orange, California, United States, 92868-3200
Contact: Samantha Reiter | 714-456-6846
Principal Investigator: Krishnansu S Tewari, MD
Recruiting
University of Colorado
Aurora, Colorado, United States, 80045
Contact: Rebecca Kissane | 720-848-7202
Principal Investigator: Monique A. Spillman, MD
Recruiting
Hartford Hospital
Hartford, Connecticut, United States, 06106
Contact: Kathy Alexander | 860-545-3553
Principal Investigator: Amy Brown, Dr
Recruiting
The Hospital of Central Connecticut
New Britain, Connecticut, United States, 06050
Contact: Siobhan Reilly | 860-224-59006718
Principal Investigator: James Hoffman, MD
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States, 33612
Contact: Jennifer Tiemann | 813-745-7272
Principal Investigator: Robert Wenham, MD
Recruiting
Northside Hospital
Atlanta, Georgia, United States, 30342
Contact: Qun Zeng | 404-845-5053
Principal Investigator: Benedict Benigno, MD
Recruiting
Northwestern University
Chicago, Illinois, United States, 60611
Contact: Rachel Bers, CCRP | 312-472-5726
Principal Investigator: Nikki Neubauer, MD
Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242
Contact: Sharon Stockman | 319-356-2015
Principal Investigator: David Bender, MD
Recruiting
Women's Cancer Center
Covington, Louisiana, United States, 70433
Contact: Cheryl Thomas | 985-892-2252
Principal Investigator: Patricia Braly, MD
Recruiting
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States, 21201
Contact: Michelle Besche | 410-328-8610
Principal Investigator: Sarah Temkin, MD
Recruiting
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
Contact: Don Dizon | 617-724-4800
Principal Investigator: Don Dizon, Dr
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Contact: Siobhan Collins | 617-632-2580
Principal Investigator: Don Dizon, Dr.
Recruiting
Washington University School of Medecine
St Louis, Missouri, United States, 63110
Contact: Lynne Lippmann | 314-362-1760
Principal Investigator: Premal Thaker, MD
Recruiting
Memorial Sloan-Kettering Cancer Institute
New York, New York, United States, 10065
Contact: Jason Konner, MD | 646-888-4219
Principal Investigator: Jason Konnor, MD
Recruiting
Hope Women's Cancer Centers / Mission Hospital, Inc.
Asheville, North Carolina, United States, 28806
Contact: Laura Murphy | 828-670-8403
Principal Investigator: Timothy Vanderkwaak, MD
Recruiting
Levine Cancer Institute
Charlotte, North Carolina, United States, 28204
Contact: Sarah Norek | 980-442-2300
Principal Investigator: David L. Tait, MD
Recruiting
Roger Maris Cancer Center
Fargo, North Dakota, United States, 58122
Contact: Collette Springman | 605-328-1384
Principal Investigator: Maria Bell, MD
Recruiting
Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43210
Contact: Leena Hiremath | 614-366-9088
Principal Investigator: David O'Malley, MD
Recruiting
Peggy and Charles Oklahoma Cancer Center
Oklahoma City, Oklahoma, United States, 73104
Contact: Michelle Stephens | 405-271-8777
Principal Investigator: Scott McMeekin, MD
Recruiting
Sanford Research/USD
Sioux Falls, South Dakota, United States, 57104
Contact: Collette Springman | 605-328-1384
Principal Investigator: Maria Bell, MD
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390-9179
Contact: Isabel Villalobos | 214-648-7010
Principal Investigator: David Scott Miller, MD
Recruiting
University of Virginia
Charlottesville, Virginia, United States, 22908
Contact: Tomothy Howland | 434-243-0032
Principal Investigator: Linda Duska, MD
Recruiting
Inova Fairfax Hospitals
Falls Church, Virginia, United States, 22024
Contact: Kelly Jeffords | 571-308-1830344
Principal Investigator: Larry Maxwell, MD
Recruiting
Henrico Doctor's Hospital
Richmond, Virginia, United States, 23229
Contact: Deidre Belcher | 804-289-4672
Principal Investigator: Cecelia Boardman, MD
Recruiting
Medizinische Universität Innsbruck
Innsbruck, Austria, 6020
Contact: Alain-Gustave Zeimet | +43 (0)50504-24155
Principal Investigator: Alain-Gustave Zeimet, Prof.Dr
Recruiting
Medizinische Universität Innsbruck
Innsbruck, Austria, 6020
Contact: Alain-Gustave Zeimet | +43 (0)50504-24155
Principal Investigator: Alain-Gustave Zeimet, Prof. Dr.
Recruiting
Minsk City Clinical Oncologic Dispensary
Minsk, Belarus
Contact: Yauheni Baranau | +375 29 627 2018
Principal Investigator: Yauheni Baranau, Dr
Recruiting
Alexandrov National Cancer centre of Belarus
Minsk, Belarus, 223040
Contact: Ivan Zhuravkin | +375 17 265 3781
Principal Investigator: Edvard Zhavrid, Dr
Recruiting
Mogilev Regional Clinical Oncologic Dispensary
Mogilev, Belarus, 212018
Contact: Elena Ezubchyk | +375 29 664 6877
Principal Investigator: Elena Ezubchyk, Dr
Recruiting
Vitebsk Regional Clinical Oncologic Dispensary
Vitebsk, Belarus, 210603
Contact: Natalia Matora | +375 21 257 2179
Principal Investigator: Valiantina Kliuchanok, Dr
Recruiting
Institut Jules Bordet
Brussels, Belgium, 1000
Contact: Joseph Kerger | +32 2 541 73 96
Principal Investigator: Joseph Kerger, Dr
Recruiting
UZ Leuven - Campus Gasthuisberg
Leuven, Belgium
Contact: Tine Op de beeck | +32 16 34 29 23
Principal Investigator: Ignace Vergote, Prof.
Recruiting
Hospital Centre Liege University_CHU Sart Tilman
Liege, Belgium, 4000
Contact: Frederic Kridelka | +32 43 67 82 50
Principal Investigator: Frederic Kridelka, Prof. Dr.
Recruiting
CHWAPI
Tournai, Belgium, 7500
Contact: Olivia Ponchau | +32 69 88 50 30
Principal Investigator: Catherine Dopchie, Dr
Recruiting
Clinical Center Banja Luka, Oncology Clinic
Banja Luka, Bosnia and Herzegovina, 78000
Contact: Zivko Vranjes, Dr | +387 65 880 811
Principal Investigator: Zivko Vranjes, Dr
Recruiting
University Clinical Hospital Mostar, Oncology clinic
Mostar, Bosnia and Herzegovina, 88000
Contact: . Inga Marijanovic, Dr | +387 61 194 686
Principal Investigator: Inga Marijanovic, Dr
Recruiting
Clinical Centre University of Sarajevo
Sarajevo, Bosnia and Herzegovina, 71000
Contact: Anes Pasic | 00 387 217 499 / 00 387 33 298
Principal Investigator: Anes Pasic, MD
Recruiting
Specialized Hospital for Active Treatment in Obstetrics and Gynecology
Pleven, Bulgaria
Contact: Grigor Gortchev | +359 887 511 531
Principal Investigator: Grigor Gortchev, Prof.
Recruiting
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Contact: Wanda Gaudon | (780) 577-8029
Principal Investigator: Katia Tonkin, Dr
Recruiting
Princess Margaret Cancer Center
Toronto, Ontario, Canada, M5G 2M9
Contact: Judy Quintos | 416-946-45015322
Principal Investigator: Amit M Oza, Dr
Recruiting
Hopital Notre Dame - CHUM
Montreal, Quebec, Canada, H2L 4M1
Contact: Bonny Choy | 514-890-800024672
Principal Investigator: Diane Provencher, Dr
Recruiting
McGill University
Montreal, Quebec, Canada, H2W 1S6
Contact: Penny Chipman | 514-398-1444
Principal Investigator: Suzy Lau, Dr
Recruiting
Royal Victoria Hospital
Montreal, Quebec, Canada, H3A 1A1
Contact: Natacha Albarracin | (514) 934-193431975
Principal Investigator: Lucy Gilbert, Dr
Recruiting
Hotel Dieu de Quebec- CHUQ
Quebec, Canada, G1R 2J6
Contact: Theresa Jones | 418 691-5181
Principal Investigator: Vincent Castonguay, Dr
Recruiting
Masarykův onkologický ústav
Brno, Czech Republic, 65653
Contact: Jana Haičmanová | 00420-543135222
Principal Investigator: Josef Chovanec, Dr
Recruiting
Fakultní nemocnice Olomouc
Olomouc, Czech Republic, 77520
Contact: Magda Šimková | 420588442522
Principal Investigator: Bohuslav Melichar, Dr
Recruiting
Všeobecná fakultní nemocnice v Praze
Praha, Czech Republic, 12851
Contact: David Cibula | 00420 224 967 481
Principal Investigator: David Cibula, Prof.
Recruiting
St James's Hospital
Dublin, Ireland, 8
Contact: Dearbhaile O'Donnell | 00 353 1 410 3973
Principal Investigator: Dearbhaile O'Donnell, Dr
Recruiting
Mater Private Hospital
Dublin, Ireland, 7
Contact: Martina Smith | 00 353 1 8034838
Principal Investigator: David Gallagher, Dr
Recruiting
Mater Misericordiae University Hospital
Dublin, Ireland, 7
Contact: Martina Smith | 00 353 1 8034838
Principal Investigator: David Gallagher, Dr
Recruiting
University Hospital Galway
Galway, Ireland
Contact: Maccon Keane | 00 353 91 544735
Principal Investigator: Maccon Keane, Dr.
Recruiting
Waterford Regional Hospital
Waterford, Ireland
Contact: Elaine S Shanahan | 00 353 51 848934
Principal Investigator: Paula Calvert, Dr
Recruiting
Barzilai Medical Center
Ashkelon, Israel, 78278
Contact: Frida Barak, Dr | 08-6745378
Principal Investigator: Frida Barak, Dr
Recruiting
Rambam Health Care Campus
Haifa, Israel, 31096
Contact: Amnon Amit, Dr | 04-8543872
Principal Investigator: Amnon Amit, Dr
Recruiting
Hadassah Hospital
Jerusalem, Israel, 91120
Contact: David Edelmann, Dr | 02-6777365
Principal Investigator: David Eldelmann, Dr
Recruiting
Davidoff Center, Rabin Medical Center
Petah-Tikva, Israel, 49100
Contact: Claude Koren, Dr | 03-9378002
Principal Investigator: Claude Koren, Dr
Recruiting
Oncology Institute Kaplan
Rehovot, Israel, 76100
Contact: Adelya Yachnin, Dr | 08-9441975
Principal Investigator: Adelya Yachnin, Dr
Recruiting
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 64239
Contact: Diana Matceyevsky, Dr | 03-6973997
Principal Investigator: Diana Matceyevsky, Dr
Recruiting
Chaim Sheba Medical Center
Tel Hashomer, Israel, 52661
Contact: Tamar Perri, Dr | 972-52-6666444
Principal Investigator: Tamar Perri, Dr
Recruiting
Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari
Bari, Italy, 70124
Contact: Luigi Selvaggi | +39 080 5478986
Principal Investigator: Luigi Selvaggi, Dr.
Recruiting
Azienda Ospedaliero-Universitaria di Modena
Modena, Italy, 41124
Contact: Roberto Sabbatini | +39 059 4222648
Principal Investigator: Roberto Sabbatini, Dr
Recruiting
Istituto Nazionale Tumori IRCCS
Napoli, Italy, 80131
Contact: Carmela Pisano | +39 081 5903637
Principal Investigator: Carmela Pisano, Dr
Recruiting
Istituto Oncologico Veneto, IRCCS
Padova, Italy, 35128
Contact: Pier Franco Conte | +39 049 8215931
Principal Investigator: Pier Franco Conte, Prof.
Recruiting
Azienda Ospedaliera Ospedali Riuniti Marche Nord
Pesaro, Italy, 61122
Contact: Giammaria Fiorentini | +39 0721 364124
Principal Investigator: Giammaria Fiorentini, Dr
Recruiting
Policlinico A. Gemelli
Rome, Italy, 00168
Contact: Giovanni Scambia | +39 06 30156279
Principal Investigator: Giovanni Scambia, Dr
Recruiting
Academic Medical Center
Amsterdam, Netherlands, 1105
Contact: Lyda ter Hofstede | trialmedonc@amc.uva.nl
Principal Investigator: Anne Marie Westermann, Dr.
Recruiting
Maastricht University Medical Center (UMC)
HX Maastricht, Netherlands, 6229
Contact: Roy Lalisang | +31 43 3876007
Principal Investigator: Roy Lalisang, Dr.
Recruiting
The Norwegian Radium Hospital
Oslo, Norway, 0310
Contact: Gunnar Kristensen | +47 22934000
Principal Investigator: Gunnar Kristensen, Dr.
Recruiting
Helse Stavanger HF, Stavanger Universitetssjukhus
Stavanger, Norway, NO-4068
Contact: Bent Fiane | 004751519470
Principal Investigator: Bent Fiane, Dr.
Recruiting
Bialostockie Centrum Onkologii
Bialystok, Poland, 15-027
Contact: Beata Mackowiak-Matejczyk | +48 85 664 67 32.
Principal Investigator: Beata Mackowiak-Matejczyk, Dr
Recruiting
I Klinika Ginekologii Onkologicznej i Ginekologii
Lublin, Poland, 20-081
Contact: Jan Kotarski, Prof. | +48815327847
Principal Investigator: Jan Kotarski, Prof.
Recruiting
Wojewodzki Szpital Specjalistyczny
Olsztyn, Poland, 10-561
Contact: Malgorzata Sikorska | +48895386563
Principal Investigator: Malgorzata Sikorska, Dr
Recruiting
NZOZ Magodent, Szpital Onkologiczny
Warszawa, Poland, 03-291
Contact: Malgorzata Stelmaszuk | +48 22 326 98 66
Principal Investigator: Malgorzata Stelmaszuk
Recruiting
Centrum Terapii Współczesnej ul.
Łódź, Poland, 90-242
Contact: Malgorzata Ułańska | +48 42 230 06 09
Principal Investigator: Malgorzata Ułańska, Dr
Recruiting
Oncolab
Craiova, Dolj county, Romania, 200385
Contact: Denis Diaconescu | 0040 251 531 088
Principal Investigator: Michael Schenker, Dr
Recruiting
Spitalul Clinic Judetean Mures
Targu Mures, Mures county, Romania, 540072
Contact: Toganel Cornelia | 0040 265 210 947
Principal Investigator: Toganel Cornelia, Dr
Recruiting
Oncology Institute "Prof. Dr. I. Chiricuta"
Cluj Npaoca, Romania, 400015
Contact: Calin Cainap | +40 264 598 361
Principal Investigator: Calin Ioan Cainap, Dr
Recruiting
Spitalul Clinic Judetean de Urgenta "Sf. Ioan cel Nou"
Suceava, Romania, 720237
Contact: Toderas Mihai | 0040230222098
Principal Investigator: Doina Elena Ganea, Dr
Recruiting
Oncomed
Timisoara, Romania, 300239
Contact: Daniela Elvira Sirbu, Dr | 0040 256 495 403
Principal Investigator: Daniela Elvira Sirbu, Dr
Recruiting
FGBU "RONC n.a. N.N. Blokhin"
Moscow, Russian Federation, 115478
Contact: Dmitry Komov | +7 499 324 7248
Principal Investigator: Dmitry Komov, Prof.
Recruiting
Nizhny Novgorod Regional Oncology Dispensary
Nizhny Novgorod, Russian Federation, 603081
Contact: Vitaliy Mihaylovich Terekhov | 007 831 4643777
Principal Investigator: Marina Matrosova, MD
Recruiting
FGBU "NIIO n.a. N.N. Petrov"
Saint-Petersburg, Russian Federation
Contact: Roman Donkikh | - + 7 (812) 439-95-15
Principal Investigator: Roman Donkikh, Dr
Recruiting
Budget Institution of Health / Leningrad Regional Oncological Dispensary
St. Petersburg, Russian Federation, 191014
Contact: Tatiana Potetyurina | +7 921 940-15-43
Principal Investigator: Olga Mikheeva, MD
Recruiting
Saint-Petersburg State Budgetary Institution Healthcare "City Clinical Oncology Center"
St. Petersburg, Russian Federation, 198255
Contact: Georgy Manikhas | +7 812 7566368
Principal Investigator: Alla Lisyanskaya, Dr
Recruiting
Republican Clinical Oncology Dispensary
Ufa, Russian Federation, 450071
Contact: Irina Rakhmatullina | +7 917 7791312
Principal Investigator: Irina Rakhmatullina, MD, PhD
Recruiting
Volgograd Regional Oncology Dispensary #3
Volzhsky, Russian Federation
Contact: Ksenia Babina | - +7 8443 310663
Principal Investigator: Ksenia Babina, Dr
Recruiting
Hospital Vall d´Hebron
Barcelona, Spain
Contact: Ana Oaknin | +34. 93.274.60.85
Principal Investigator: Ana Oaknin, Dr
Recruiting
Hospital Universitario 12 de Octubre
Madrid, Spain, 28045
Contact: Jesús Jiménez | 0034 913908376
Principal Investigator: Jesús Jiménez, Dr
Recruiting
Ramon Y Cajal Hospital
Madrid, Spain, 28034
Contact: Luis Barba | 0034913368263
Principal Investigator: Eva Guerra, Dr.
Recruiting
Hospital Clínico San Carlos
Madrid, Spain, 28040
Contact: Antonio Casado | +34 91 330 30 007551/7549
Principal Investigator: Antonio Casado, Dr.
Recruiting
Instituto Valenciano de Oncologia
Valencia, Spain, 46009
Contact: Pedro Mallol | 96 110 46 06
Principal Investigator: Ignacio Romero, Dr.
Recruiting
Zina Memorial Cancer Hospital (LISSOD)
Plyuty, Kiev region, Ukraine, 08720
Contact: Alla Lychko | 00380445209401
Principal Investigator: Alla Vinnytska, Dr
Recruiting
Municipal institution "Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4"
Dnepropetrovsk, Ukraine, 49102
Contact: Illiya Balakin | 00380567417418
Principal Investigator: Igor Bondarenko
Recruiting
CCMP I Donetsk Regional Anticancer Center
Donetsk, Ukraine, 83092
Contact: Pavlo Lyfar | 00380622239503
Principal Investigator: Natalia Lisovska, Dr
Recruiting
Public health enterprise "Kharkov regional Clinical Oncological Center"
Kharkov, Ukraine, 61070
Contact: Vladislav Bakhtalovskiy | +380573150124
Principal Investigator: Yuri Vinnyk, Dr.
Recruiting
Kiev City Clinical Oncology Center
Kiev, Ukraine, 03115
Contact: Olena Manzhura | 00380444508239
Principal Investigator: Olena Manzhura, MD
Recruiting
Zakarpatskyi Regional Clinical Oncology Dispensary
Uzhgorod, Ukraine, 88014
Contact: Taras Shlakhta | +380312615613
Principal Investigator: Andriy Rusyn, Dr
Recruiting
Vinnitsa Regional Clinical Oncology Dispensary
Vinnitsa, Ukraine, 21029
Contact: Oksana Mashevska | 00380432511434
Principal Investigator: Serhiy Odarchenko, Dr
Recruiting
The Royal Marsden Hospital NHS Foundation Trust
Sutton, Surrey, United Kingdom, SM2 5PT
Contact: Susana Banerjee | 00 44 208 661 3539
Principal Investigator: Susana Banerjee, Dr
Recruiting
The Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, Wirral, United Kingdom, CH63 4JY
Contact: Laurie Lomax | +44 151 482 78044926
Principal Investigator: John Green, Dr
Recruiting
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, United Kingdom, CV2 2DX
Contact: Tracey Preston | +44 2476 96747627476
Principal Investigator: Christopher Poole, Dr.
Recruiting
Imperial college Healthcare NHS Trust
London, United Kingdom
Contact: Daisy Shinmar | 00 44 208 383 6457
Principal Investigator: Hani Gabra, Prof.
Recruiting
Nottingham City Hospital NHS Trust
Nottingham, United Kingdom, NG5 1PB
Contact: Stephan Chan | 0044 115 969 116957298
Principal Investigator: Stephan Chan, Dr
Recruiting